Respiree

Singapore, Singapore

Respiree is a deep tech startup that provides AI-assisted virtual care platforms used to support monitoring and managing clinical deterioration across multiple spaces within healthcare’s care continuum, e.g, post-operative, in-floor, hospital-at-home, post-discharge and outpatient chronic disease management. Respiree’s cardiopulmonary wearable sensors and physiologic analysis software are now medically approved by Singapore’s Health Sciences Authority (HSA), the European Commission’s CE certification under the Medical Device Directive and Australia’s Therapeutics Good Administration (TGA). Respiree is also in the process of securing approval from the US Food and Drug Administration (FDA) to commercialize its product globally.